搜尋結果
1 天前 · On September 11, 2023, the updated Moderna and Pfizer–BioNTech mRNA vaccines (i.e., 2023–2024 formulas) against coronavirus disease 2019 (Covid-19) containing the severe acute respiratory ...
1 天前 · Boosters that target the omicron subvariants of SARS-CoV-2 are still providing reasonably durable protection against infection, hospitalization and death from COVID-19, according to new data from ...
1 天前 · In late 2022, because Omicron variants quickly dominated the global viral landscape, vaccine manufacturers accordingly developed original and Omicron BA.1 or BA.4/5 bivalent vaccines [4-6]. In 2023, Omicron XBB sublineages became responsible for a large proportion of COVID-19.
5 天前 · The KP. 2 and KP. 1 variants are part of the “FLiRT” group, which originated from the Omicron branch of the coronavirus. “While there is no indication that the circulating variants are more ...
3 天前 · Background Taiwan, deeply impacted by the 2003 SARS outbreak, promptly implemented rigorous infection control and prevention (ICP) measures in January 2020 to combat the global COVID-19 pandemic. This cross-sectional serologic study was conducted among healthcare workers (HCWs) in a tertiary care hospital in Taiwan from August 1, 2022, to February 28, 2023. The study aimed to assess HCWs ...
1 天前 · News Release 29-May-2024. Researchers take step toward development of universal COVID-19 antibodies. Texas Biomed and partners licensing new SARS-CoV-2 antibody targeting newest strains of COVID ...
1 天前 · The Conversation — We’ve now been living with COVID-19 for well over 4 years. Although there’s still much to learn about SARS-CoV-2 (the virus that causes COVID-19) at least 1 thing seems clear: it’s here to stay. From the original Wuhan variant, to Delta, to Omicron, and several others in between, the virus has continued to evolve.
